These findings indicate enhanced energy metabolism in human atherosclerotic plaques of TET2 CHIP CAD carriers, potentially contributing to the more inflammatory and metabolically active plaque phenotype associated with this mutation. Here, STUB1 is linked to coronary artery disorder.